Molecular and cellular mechanisms regulating vascular function and structure - Implications in the pathogenesis of hypertension

Canadian Journal of Cardiology

Volumn 16, Issue 9, 2000, Pages 1137-1146

  Touyz, R M ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Angiotensin; Arteries; Renin; Signal transduction; Smooth muscle; Stress

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; GROWTH FACTOR; HUMORAL ANTIBODY; REACTIVE OXYGEN METABOLITE;

BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CYTOLOGY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; ESSENTIAL HYPERTENSION; EXTRACELLULAR MATRIX; GENETIC SUSCEPTIBILITY; HEMODYNAMICS; HUMAN; MITOGENESIS; OXIDATIVE STRESS; PHOSPHORYLATION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE;

HEMODYNAMICS; HUMAN; HYPERTENSION; MOLECULAR BIOLOGY; MUSCLE, SMOOTH, VASCULAR; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; VENTRICULAR REMODELING;

EID: 0033793941     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Essential hypertension. Part I. Definition and etiology
2. Factors controlling growth and matrix production in vascular smooth muscle and glomerular cells
3. Resistance control in hypertension
4. Structural factor in primary and secondary hypertension
5. Structure and function of small arteries
6. Vascular remodelling
7. Reactivity of small blood vessels in hypertension: Relation with structural changes
8. Effect of pressurization on mechanical properties of mesenteric small arteries from spontaneously hypertensive rats
9. Effects of losartan and enalapril on small artery structure in hypertensive rats
10. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension
11. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a three-dimensional dissector
12. Structural alterations of blood vessels in hypertensive rats
13. Hyperplasia of medial smooth muscle cells is not involved in vascular hypertrophy in hypertension
14. Vascular smooth muscle cell hypertrophy vs hyperplasia
15. Arterial vasodilation and vascular connective tissue changes in spontaneously hypertensive rats
16. Apoptosis in vasculature of spontaneously hypertensive rats: Effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist
17. Vascular smooth muscle in hypertension
18. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients
19. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1
20. Impaired vasodilator function in hypertension. The role of alterations in receptor-G protein coupling
21. Signal transduction in hypertension. Part 2
22. Biology of blood vessels in hypertension
23. High sensitivity of hypertensive aortic myocytes to norepinephrine and angiotensin
24. MEK inhibition attenuates Ang II-mediated signalling and contraction in SHR vascular smooth muscle cells
25. Molecular mechanisms of the exaggerated growth of vascular smooth muscle cells in hypertension
26. Angiotensin II type 1 receptor A1166C polymorphism is associated with an increased response to angiotensin II in human arteries
27. Regulation of matrix proteins and impact on vascular structure
28. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
29. Differential effects of Ang II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo
30. Growth factors and mitogen-activated protein kinases
31. Multiple autocrine growth factors modulate vascular smooth muscle cell growth responses to Ang II
32. Ang II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-β synthesis via transcriptional and posttranscriptional mechanisms
33. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system
34. Pulse pressure and echocardiographic findings in essential hypertension
35. Collagen I and III and mechanical properties of conduit arteries in rats with genetic hypertension
36. Ang II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts
37. Effects and interactions of ET-1 and Ang II on matrix protein expression and synthesis and mesangial cell growth
38. Ang II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: Evidence for an endothelin-mediated mechanism
39. Ang II increases plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells
40. Ang II in cell growth and matrix production
41. Comparison of effects of angiotensin I-converting enzyme inhibition and beta blockade on function of small arteries from hypertensive patients
42. Correction of remodelling and function of small arteries in human hypertension by cilazapril, an angiotensin 1-converting enzyme inhibitor
43. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin II receptor antagonist losartan
44. Vascular protection with newer antihypertensive agents
45. Effects of a beta blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension
46. Effect of long-term inhibition on myocardial tissue in hypertensives stroke-prone rats
47. Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in SHR
48. Reversal of cardiac fibrosis in DOCA-salt hypertensive rats by inhibition of the renin-angiotensin system
49. Renal afferent arteriolar structure in the genetically hypertensive rat and the ability of losartan and enalapril to cause structural remodelling
50. Abnormalities of the extracellular degradation of collagen type I in essential hypertension
51. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
52. Vascular biology of endothelin
53. Angiotensin II increases tissue endothelin and induced vascular hypertrophy in vivo: Reversal by ET(A) receptor antagonist
54. Endothelins as cardiovascular peptides
55. Vasoactive hormones and renal sclerosis
56. Involvement of Ang II and ET-1 on matrix protein production and renal sclerosis
57. Endothelins are potent vasoconstrictors, and much more besides
58. Clinical significance of endothelin in cardiovascular disease
59. Effect of a non-selective endothelin antagonist on vascular remodelling in DOCA-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy
60. DOCA plus salt induces overexpression of vascular ET-1 and severe vascular hypertrophy in SHR
61. Effects of a selective endothelin A-receptor antagonist, BQ-123, in salt-loaded stroke-prone spontaneously hypertensive rats
62. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats
63. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition
64. Vascular endothelin-1 gene expression and effect of an endothelin A receptor antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats
65. Endothelin A receptor blockade improves renal function and doubles the life span of stroke-prone spontaneously hypertensive rats
66. Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats
67. Ligand occupancy of the αVβ3 is necessary for smooth muscle cells to migrate in response to IGF-1
68. IGF-1 increases bFGF-induced mitogenesis and upregulates FGFR-1 in rabbit vascular smooth muscle cells
69. Intracellular signalling pathways required for rat vascular smooth muscle cell migration. Interactions between basic fibroblast growth factor and platelet derived growth factor
70. The intima: Soil for atherosclerosis and restenosis
71. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cell. Possible mediator of the response to vascular injury
72. Effects of transforming growth factor-beta1 on renal extracellular matrix components and their regulating proteins
73. Pulsed Doppler: Diameter, blood flow velocity and volumic blood flow of the brachial artery in sustained essential hypertension
74. Hypertensive vascular disease and inflammation: Mechanical and humoral mechanisms
75. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: Role of a superoxide-producing NADH oxidase
76. Mechanical influences on vascular smooth muscle cell function
77. Mechanical strain induced growth of vascular smooth muscle cells via autocrine action of PDGF
78. Cyclic strain induces an oxidative stress in endothelial cells
79. Autocrine release of Ang II mediates stretch-induced hypertrophy of cardiac myocytes in vitro
80. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ cultures model of rat aorta
81. + current in vascular endothelial cells
82. Ion channels and vascular tone
83. Role of superoxide anions in the mediation of endothelium-dependent contractions
84. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells
85. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression
86. Cellular and molecular mechanisms of endothelial cell dysfunction
87. Inactivation of endothelium derived relaxing factor by oxidized lipoproteins
88. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension
89. Superoxide anion production is increased in a model of genetic hypertension. Role of endothelium
90. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: Contribution to alterations of vasomotor tone
91. Vascular NAD(P)H oxidase is involved in enhanced superoxide production in SHR
92. Combination of vitamins C and E alters the response to coronary balloon injury in the pig
93. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide
94. Endothelial function in hypertension. The role of superoxide anion
95. Reactive oxygen species of signal transduction in cardiovascular disease
96. Oxidative stress in vascular damage in hypertension
97. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: A new perspective
98. Antihypertensive and vasodilator actions of antioxidants in SHR
99. Chronic antioxidant use and changes in endothelial dysfunction: A review of clinical investigations